CardioKinetix, Inc.

Device Transactions Device companies finished 2014 raising $902 million during the fourth quarter, bringing the full-year financing total to $4 billion, remaining exactly flat from 2013's figure. ( Se

Edwards Lifesciences Corp. has taken an option to acquire heart failure device developer CardioKinetix Inc. after leading a $50 million financing round in the company, Edwards announced Dec. 8 d

Edwards Lifesciences Corp. ’s position as leader of the transcatheter aortic valve implantation (TAVI) market is looking secure. Furthermore, the segment could end up being even bigger than anticipat

Heart failure (HF), the leading cause of hospitalization in Americans over age 65, is both progressive and progressing. Driven by the aging population and an increase in ischemic heart disease, hypert